Es gab 50 kürzliche Insider-Transaktionen für NextCure, Inc. (NXTC), darunter 48 Käufe und 0 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $5.64M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Richman Michael, Cobourn Steven P., Mayer Timothy. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — NXTC
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-30 |
Richman Michael |
President & CEO |
RSU-Zuteilung |
38,190 |
$10.85 |
$414.36K |
38,190 |
| 2026-01-30 |
Cobourn Steven P. |
Chief Financial Officer |
RSU-Zuteilung |
14,670 |
$10.85 |
$159.17K |
14,670 |
| 2026-01-30 |
Mayer Timothy |
Chief Operating Officer |
RSU-Zuteilung |
14,670 |
$10.85 |
$159.17K |
14,670 |
| 2026-01-30 |
Kundu Sourav |
Sr VP, Dev. & Mfg. |
RSU-Zuteilung |
8,270 |
$10.85 |
$89.73K |
8,270 |
| 2026-01-30 |
Shaw Kevin G. |
Sr VP, General Counsel |
RSU-Zuteilung |
8,270 |
$10.85 |
$89.73K |
8,270 |
| 2026-01-30 |
Guha Udayan |
Chief Medical Officer |
RSU-Zuteilung |
14,670 |
$10.85 |
$159.17K |
14,670 |
| 2025-06-20 |
Simcere Zaiming, Inc. |
10 Percent Owner |
Unbekannt |
- |
- |
- |
338,636 |
| 2025-06-20 |
Kabakoff David S |
Director |
RSU-Zuteilung |
28,050 |
$0.47 |
$13.18K |
28,050 |
| 2025-06-20 |
Jones Elaine V |
Director |
RSU-Zuteilung |
18,700 |
$0.47 |
$8.79K |
18,700 |
| 2025-06-20 |
Webster Stephen W |
Director |
RSU-Zuteilung |
18,700 |
$0.47 |
$8.79K |
18,700 |
| 2025-06-20 |
Houston John G |
Director |
RSU-Zuteilung |
18,700 |
$0.47 |
$8.79K |
18,700 |
| 2025-06-20 |
Feigal Ellen |
Director |
RSU-Zuteilung |
18,700 |
$0.47 |
$8.79K |
18,700 |
| 2025-06-20 |
Borgman Anne Elizabeth |
Director |
RSU-Zuteilung |
18,700 |
$0.47 |
$8.79K |
18,700 |
| 2025-02-01 |
Guha Udayan |
Chief Medical Officer |
Unbekannt |
117,375 |
$0.80 |
$94.46K |
- |
| 2025-01-31 |
Richman Michael |
President & CEO |
RSU-Zuteilung |
305,500 |
$0.80 |
$245.87K |
305,500 |
| 2025-01-31 |
Cobourn Steven P. |
Chief Financial Officer |
RSU-Zuteilung |
117,375 |
$0.80 |
$94.46K |
117,375 |
| 2025-01-31 |
Langermann Sol |
Chief Scientific Officer |
RSU-Zuteilung |
117,375 |
$0.80 |
$94.46K |
117,375 |
| 2025-01-31 |
Mayer Timothy |
Chief Operating Officer |
RSU-Zuteilung |
117,375 |
$0.80 |
$94.46K |
117,375 |
| 2025-01-31 |
Kundu Sourav |
Sr VP, Dev. & Mfg. |
RSU-Zuteilung |
66,125 |
$0.80 |
$53.22K |
66,125 |
| 2025-01-31 |
Shaw Kevin G. |
Sr VP, General Counsel |
RSU-Zuteilung |
66,125 |
$0.80 |
$53.22K |
66,125 |
| 2024-06-20 |
Kabakoff David S |
Director |
RSU-Zuteilung |
28,050 |
$1.50 |
$42.08K |
28,050 |
| 2024-06-20 |
Jones Elaine V |
Director |
RSU-Zuteilung |
18,700 |
$1.50 |
$28.05K |
18,700 |
| 2024-06-20 |
Webster Stephen W |
Director |
RSU-Zuteilung |
18,700 |
$1.50 |
$28.05K |
18,700 |
| 2024-06-20 |
Houston John G |
Director |
RSU-Zuteilung |
18,700 |
$1.50 |
$28.05K |
18,700 |
| 2024-06-20 |
Feigal Ellen |
Director |
RSU-Zuteilung |
18,700 |
$1.50 |
$28.05K |
18,700 |
| 2024-06-20 |
Borgman Anne Elizabeth |
Director |
RSU-Zuteilung |
18,700 |
$1.50 |
$28.05K |
18,700 |
| 2024-03-29 |
Richman Michael |
President & CEO |
RSU-Zuteilung |
244,400 |
$2.23 |
$545.01K |
244,400 |
| 2024-03-29 |
Cobourn Steven P. |
Chief Financial Officer |
RSU-Zuteilung |
93,900 |
$2.23 |
$209.4K |
93,900 |
| 2024-03-29 |
Langermann Sol |
Chief Scientific Officer |
RSU-Zuteilung |
93,900 |
$2.23 |
$209.4K |
93,900 |
| 2024-03-29 |
Mayer Timothy |
Chief Operating Officer |
RSU-Zuteilung |
93,900 |
$2.23 |
$209.4K |
93,900 |
| 2024-03-29 |
Myint Han |
Chief Medical Officer |
RSU-Zuteilung |
93,900 |
$2.23 |
$209.4K |
93,900 |
| 2024-03-29 |
Kundu Sourav |
Sr VP, Dev. & Mfg. |
RSU-Zuteilung |
52,900 |
$2.23 |
$117.97K |
52,900 |
| 2024-03-29 |
Shaw Kevin G. |
Sr VP, General Counsel |
RSU-Zuteilung |
93,900 |
$2.23 |
$209.4K |
93,900 |
| 2024-01-31 |
Richman Michael |
President & CEO |
RSU-Zuteilung |
305,500 |
$1.22 |
$372.71K |
305,500 |
| 2024-01-31 |
Cobourn Steven P. |
Chief Financial Officer |
RSU-Zuteilung |
117,375 |
$1.22 |
$143.2K |
117,375 |
| 2024-01-31 |
Langermann Sol |
Chief Scientific Officer |
RSU-Zuteilung |
117,375 |
$1.22 |
$143.2K |
117,375 |
| 2024-01-31 |
Mayer Timothy |
Chief Operating Officer |
RSU-Zuteilung |
117,375 |
$1.22 |
$143.2K |
117,375 |
| 2024-01-31 |
Myint Han |
Chief Medical Officer |
RSU-Zuteilung |
117,375 |
$1.22 |
$143.2K |
117,375 |
| 2024-01-31 |
Kundu Sourav |
Sr VP, Dev. & Mfg. |
RSU-Zuteilung |
66,125 |
$1.22 |
$80.67K |
66,125 |
| 2024-01-31 |
Shaw Kevin G. |
Sr VP, General Counsel |
RSU-Zuteilung |
66,125 |
$1.22 |
$80.67K |
66,125 |
| 2023-06-22 |
Kabakoff David S |
Director |
RSU-Zuteilung |
14,250 |
$1.62 |
$23.09K |
14,250 |
| 2023-06-22 |
Jones Elaine V |
Director |
RSU-Zuteilung |
14,250 |
$1.62 |
$23.09K |
14,250 |
| 2023-06-22 |
Webster Stephen W |
Director |
RSU-Zuteilung |
14,250 |
$1.62 |
$23.09K |
14,250 |
| 2023-06-22 |
Khuong Chau Quang |
Director |
RSU-Zuteilung |
14,250 |
$1.62 |
$23.09K |
14,250 |
| 2023-06-22 |
Nicholson Garry A |
Director |
RSU-Zuteilung |
14,250 |
$1.62 |
$23.09K |
14,250 |
| 2023-06-22 |
Houston John G |
Director |
RSU-Zuteilung |
14,250 |
$1.62 |
$23.09K |
14,250 |
| 2023-06-22 |
Feigal Ellen |
Director |
RSU-Zuteilung |
14,250 |
$1.62 |
$23.09K |
14,250 |
| 2023-06-22 |
Borgman Anne Elizabeth |
Director |
RSU-Zuteilung |
14,250 |
$1.62 |
$23.09K |
14,250 |
| 2023-02-28 |
Richman Michael |
Officer |
RSU-Zuteilung |
309,000 |
$1.55 |
$478.95K |
309,000 |
| 2023-02-28 |
Cobourn Steven P. |
Officer |
RSU-Zuteilung |
135,000 |
$1.55 |
$209.25K |
135,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
